Biologics and regenerative medicine refer to therapies that aim to support the body’s natural healing processes by influencing inflammation, cellular signaling, and tissue environment. In orthopedics, these approaches are explored as adjuncts to conventional care, not guaranteed solutions or replacements for surgery.
Because this field is rapidly evolving, education, transparency, and appropriate patient selection are essential.
What Falls Under Biologics?
Biologic therapies differ in source, composition, mechanism, and regulatory status. Commonly discussed options include platelet-based therapies, tissue-derived products, and cell-signaling approaches. These therapies are not interchangeable and should be evaluated individually based on diagnosis, disease severity, and patient goals.
Are These Treatments FDA-Approved?
Most biologic therapies marketed for orthopedic use are not FDA-approved as treatments for specific conditions. The FDA regulates biologic products based on how they are sourced, processed, and used. As a result, many biologic therapies remain investigational.
Why Results Vary
Outcomes with biologic therapies vary widely. Factors such as tissue health, degree of degeneration, metabolic status, mechanical alignment, and the specific biologic used all influence response. While some patients experience symptom improvement, others may see limited or no benefit.
U.S. vs International Biologic Clinics
Some patients consider regenerative treatments offered outside the United States. Regulatory oversight, sourcing standards, and clinical follow-up can differ significantly between countries. U.S.-based biologic care operates under stricter regulatory frameworks designed to prioritize patient safety, product quality, and transparency - even when therapies are investigational.
Frequently Asked Questions
Are these treatments experimental?
Many biologic therapies are considered investigational. While early research may be promising, high-quality clinical evidence is still evolving.
Do biologics cure arthritis?
No. Biologic therapies do not cure arthritis or reverse advanced cartilage loss. In select early cases, they may help manage symptoms or support joint function.
Can biologics replace surgery?
No. Biologic therapies do not replace surgery when mechanical correction or joint replacement is clearly indicated.
Who may be a candidate for regenerative therapies?
Patients with certain tendon, ligament, cartilage, or early degenerative joint conditions who have not responded to conservative care may be considered. Advanced joint destruction, infection, malignancy, or unrealistic expectations may limit candidacy.
Learn More About Your Options
Regenerative medicine is not one-size-fits-all. Determining whether a biologic therapy may be appropriate depends on diagnosis, overall health, and treatment goals.
Schedule an educational consultation to learn whether this approach may be appropriate for you.